Newsroom

Check out CRN's latest press releases in our feed, or search for your topics of interest. Members of the media, learn more here about working with CRN for science-based information for your reporting.

Authored between
OCTOBER 26, 2023 – CRN announced the winners of its graduate student award program that grants the next generation of nutrition scientists and practitioners access to its annual Science in Session symposium, that took place Tuesday, Oct. 3.
Read more
OCTOBER 26, 2023 – CRN today expressed disappointment in the passage of a new law in New York State that will ban the sale of weight loss and sports nutrition dietary supplements to consumers under the age of 18.
Read more
OCTOBER 5, 2023—CRN the leading trade association for the dietary supplement and functional food industry, today announced findings from its anticipated annual survey of U.S. adults, conducted by Ipsos.
Read more
SEPTEMBER 25, 2023 — CRN last week filed a petition with the Federal Trade Commission (FTC) requesting the Commission clarify certain aspects of its new Health Products Compliance Guidance.
Read more
SEPTEMBER 5, 2023— CRN today extends its deepest condolences to the family and friends of Gov. Bill Richardson, who passed away on Sept. 1.  The two-term Democratic Governor of New Mexico and U.S. Ambassador to the U.N. was instrumental in passage of landmark dietary supplements regulation. 
Read more
AUGUST 25, 2023 — CRN is pleased to announce that that FDA Commissioner Robert M. Califf, M.D., will address attendees during its Now New Next conference on Wednesday, Oct. 4, via a virtual fireside chat with CRN President & CEO Steve Mister. 
Read more
AUGUST 23, 2023—CRN provides its perspective on a JAMA Cardiology report on fish oil health claims.
Read more
AUGUST 23, 2023 – CRN applauds the selection of James “Jim” Jones to serve as the first Deputy Commissioner for Human Foods at FDA, an appointment the agency announced earlier today, and welcomes Mr. Jones to the Agency. 
Read more
AUGUST 18, 2023 —WASHINGTON – CRN has submitted its responses to a Congressional RFI (Request for Information) seeking comprehensive information from key industry stakeholders on CBD.
Read more
JULY 27, 2023 — CRN today provided written testimony to the U.S. House of Representatives Committee on Oversight and Accountability, Subcommittee on Health Care and Financial Services, asking that Congress demand FDA complete the work Congress directed the agency to do under the 2018 Farm Bill by permitting CBD and other hemp-derived cannabinoids to be lawfully marketed as dietary supplements using the appropriate safeguards found in the existing law.
Read more